Tanya Simuni, MD, FAAN

Dr. Tanya Simuni heads the Parkinson’s Disease and Movement Disorders Center at Northwestern University Feinberg School of Medicine. An internationally recognized leader in Parkinson’s disease research, she has led major therapeutic and biomarker studies focused on disease modification, progression, and prevention. Dr. Simuni serves on the senior leadership team of the Parkinson’s Precision Medicine Initiative (PPMI). She leads the international effort to establish a biologically based definition and staging system for Neuronal Alpha-Synuclein Disease (NSD). She is the Principal Investigator of the Path to Prevention (P2P) Platform Trial that will be recruiting individuals with early stages of NSD, helping shape the future of early detection and preventive interventions in Parkinson’s disease. Dr. Simuni is an active member of the American Academy of Neurology,

American Neurological Association, the Movement Disorders Society as well as the PSG.